IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $76,820 | +87.4% | 219,488 | +100.0% | 0.00% | – |
Q3 2022 | $41,000 | -18.0% | 109,744 | 0.0% | 0.00% | – |
Q2 2022 | $50,000 | -9.1% | 109,744 | 0.0% | 0.00% | – |
Q1 2022 | $55,000 | -12.7% | 109,744 | 0.0% | 0.00% | – |
Q4 2021 | $63,000 | -44.2% | 109,744 | 0.0% | 0.00% | – |
Q3 2021 | $113,000 | -14.4% | 109,744 | 0.0% | 0.00% | – |
Q2 2021 | $132,000 | +388.9% | 109,744 | +437.7% | 0.00% | – |
Q1 2021 | $27,000 | -60.3% | 20,410 | +10.9% | 0.00% | – |
Q4 2020 | $68,000 | +74.4% | 18,410 | 0.0% | 0.00% | – |
Q3 2020 | $39,000 | -7.1% | 18,410 | -20.7% | 0.00% | – |
Q2 2020 | $42,000 | +35.5% | 23,212 | 0.0% | 0.00% | – |
Q1 2020 | $31,000 | -26.2% | 23,212 | 0.0% | 0.00% | – |
Q4 2019 | $42,000 | -46.8% | 23,212 | -14.7% | 0.00% | – |
Q3 2019 | $79,000 | +2.6% | 27,212 | -5.4% | 0.00% | – |
Q2 2019 | $77,000 | -92.1% | 28,774 | -92.5% | 0.00% | – |
Q1 2019 | $979,000 | -17.1% | 383,988 | -9.9% | 0.00% | – |
Q4 2018 | $1,181,000 | -62.5% | 426,217 | +20.6% | 0.00% | – |
Q3 2018 | $3,149,000 | – | 353,379 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 629,340 | $5,607,000 | 0.82% |
Baker Brothers Advisors | 4,833,897 | $43,070,000 | 0.28% |
Kassirer Asset Management Corp | 19,341 | $172,000 | 0.11% |
Virtus ETF Advisers LLC | 34,596 | $308,000 | 0.03% |
Palo Alto Investors LP | 77,044 | $686,000 | 0.03% |
ROPES WEALTH ADVISORS LLC | 12,500 | $111,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 147,560 | $1,280,000 | 0.03% |
Candriam S.C.A. | 195,000 | $1,737,000 | 0.02% |
NATIXIS | 429,816 | $3,830,000 | 0.02% |
Cordasco Financial Network | 1,875 | $17,000 | 0.02% |